Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura

计划入组 20 人 · 首次发布于 2012 年 4 月 5 日

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

计划入组 100 人 · 首次发布于 2023 年 11 月 18 日

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

计划入组 19 人 · 首次发布于 2006 年 8 月 10 日

Caplacizumab(Cablivi)

Idiopathic Pulmonary Fibrosis(Hepion)

Idiopathic pulmonary fibrosis (Surrozen)

Galapagos

Belgium

NLS Pharmaceutics

Switzerland

Veracyte

United States

Thrombocytopenia Treatment Market Shows Promising Growth with Novel Therapies and Clinical Trials

Rituxan Approved in Japan for Pediatric Chronic ITP

Novartis Ianalumab Combination Shows 45% Improvement in ITP Disease Control in Phase III Trial